Philippines

Number of resources: 50

Longitudinal ocular survey of 202 Filipino patients with multi-bacillary (MB) leprosy treated with 2 year WHO-multiple drug therapy.

 
Ravanes JM, Cellona RV, Balagon M, Abalos RM, Walsh GP, Walsh DS. Longitudinal ocular survey of 202 Filipino patients with multi-bacillary (MB) leprosy treated with 2 year WHO-multiple drug therapy. Southeast Asian J Trop Med Public Health. 2011;42(2):323-30.

Leprosy in the Philippines: a review.

 
Handog EB, Gabriel MT, Co CC. Leprosy in the Philippines: a review. Int J Dermatol. 2011;50(5):573-81.

Developing guidelines to strengthen participation of persons affected by leprosy in leprosy services : Developing guidelines to strengthen participation of persons affected by leprosy in leprosy services: (Report of the meeting, 9-10 June, Manila, Philipp

 
Bam S. Developing guidelines to strengthen participation of persons affected by leprosy in leprosy services : Developing guidelines to strengthen participation of persons affected by leprosy in leprosy services: (Report of the meeting, 9-10 June, Manila, Philipp. New Delhi: WHO Regional Office for South-East Asia; 2010.

Impacts of the diagnosis of leprosy and of visible impairments amongst people affected by leprosy in Cebu, the Philippines.

 
Boku N, Lockwood DN, Balagon MV, Pardillo FE, Maghanoy AA, Mallari IB, et al. Impacts of the diagnosis of leprosy and of visible impairments amongst people affected by leprosy in Cebu, the Philippines. Lepr Rev. 2010;81(2):111-20.

Philippine CBR manual: an inclusive development strategy

 
McGlade B, Mendoza VE. Philippine CBR manual: an inclusive development strategy. Manila: CBM; 2009.

Long-term relapse risk of multibacillary leprosy after completion of 2 years of multiple drug therapy (WHO-MDT) in Cebu, Philippines.

 
Balagon MF, Cellona RV, Cruz ED, Burgos JA, Abalos RM, Walsh GP, et al. Long-term relapse risk of multibacillary leprosy after completion of 2 years of multiple drug therapy (WHO-MDT) in Cebu, Philippines. Am J Trop Med Hyg. 2009;81(5):895-9.

Population-based molecular epidemiology of leprosy in Cebu, Philippines.

 
Sakamuri RM, Kimura M, Li W, Kim H-, Lee H, Kiran MD, et al. Population-based molecular epidemiology of leprosy in Cebu, Philippines. J Clin Microbiol. 2009;47(9):2844-54.

A continuation: study and characterisation of Mycobacterium leprae short tandem repeat genotypes and transmission of leprosy in Cebu, Philippines.

 
Sakamuri RM, Harrison J, Gelber R, Saunderson P, Brennan PJ, Balagon M, et al. A continuation: study and characterisation of Mycobacterium leprae short tandem repeat genotypes and transmission of leprosy in Cebu, Philippines. Lepr Rev. 2009;80(3):272-9.

Noncompliance with the world health organization-multidrug therapy among leprosy patients in Cebu, Philippines: its causes and implications on the leprosy control program.

 
Honrado ER, Tallo V, Balis AC, Chan GP, Cho SN. Noncompliance with the world health organization-multidrug therapy among leprosy patients in Cebu, Philippines: its causes and implications on the leprosy control program. Dermatol Clin. 2008;26(2):221-9, vi.

Epidemiological review of leprosy in the Western Pacific region : 2007

 
Epidemiological review of leprosy in the Western Pacific region : 2007. Manila: WHO Regional Office for the Western Pacific Region; 2007.

The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines.

 
Matsuoka M, Budiawan T, Aye KS, Kyaw K, Tan EV, Cruz ED, et al. The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines. Lepr Rev. 2007;78(4):343-52.

Status report on leprosy in the WHO Western Pacific region : 2002

 
Status report on leprosy in the WHO Western Pacific region : 2002. Manila: WHO Regional Office for the Western Pacific; 2004.

Overview and epidemiological review of leprosy in the WHO Western Pacific region : 1991-2001

 
Overview and epidemiological review of leprosy in the WHO Western Pacific region : 1991-2001. Manila: WHO Regional Office for the Western Pacific; 2003.

Eye disease in multibacillary leprosy patients at the time of their leprosy diagnosis: findings from the Longitudinal Study of Ocular Leprosy (LOSOL) in India, the Philippines and Ethiopia.

 
Courtright P, Daniel E, Daniel E, Ravanes J, Mengistu F, Belachew M, et al. Eye disease in multibacillary leprosy patients at the time of their leprosy diagnosis: findings from the Longitudinal Study of Ocular Leprosy (LOSOL) in India, the Philippines and Ethiopia. Lepr Rev. 2002;73(3):225-38.

Multidrug resistant Mycobacterium leprae from patients with leprosy.

 
Maeda S, Matsuoka M, Nakata N, Kai M, Maeda Y, Hashimoto K, et al. Multidrug resistant Mycobacterium leprae from patients with leprosy. Antimicrob Agents Chemother. 2001;45(12):3635-9.

Decentralization of health systems: Preliminary review of four country case of studies

 
Bossert T, Beauvais J, Bowser D. Decentralization of health systems: Preliminary review of four country case of studies. Bethesda: Partnerships for Health Reform; 2000.

Detection of new leprosy cases at a walk-in skin clinic in Cebu City, Philippines, highlights surveillance.

 
Balagon MV, Cellona RV, Fajardo TT, Abalos RM, Walsh DS, Villahermosa LG, et al. Detection of new leprosy cases at a walk-in skin clinic in Cebu City, Philippines, highlights surveillance. Int J Dermatol. 1999;38(10):796-7.

Leprosy elimination campaign (LEC) in the Philippines.

 
Villarama JB. Leprosy elimination campaign (LEC) in the Philippines. Lepr Rev. 1999;70(4):487-94.
Syndicate content